Bispecific antibody CAP256.J3LS targets V2-apex and CD4-binding sites with high breadth and potency
Antibody CAP256-VRC26.25 targets the second hypervariable region (V2) at the apex of the HIV envelope (Env) trimer with extraordinary neutralization potency, although less than optimal breadth. To improve breadth, we linked the light chain of CAP256V2LS, an optimized version of CAP256-VRC26.25 curre...
Saved in:
| Main Authors: | Baoshan Zhang, Jason Gorman, Young D. Kwon, Amarendra Pegu, Cara W. Chao, Tracy Liu, Mangaiarkarasi Asokan, Michael F. Bender, Tatsiana Bylund, Leland Damron, Deepika Gollapudi, Paula Lei, Yile Li, Cuiping Liu, Mark K. Louder, Krisha McKee, Adam S. Olia, Reda Rawi, Arne Schön, Shuishu Wang, Eun Sung Yang, Yongping Yang, Kevin Carlton, Nicole A. Doria-Rose, Lawrence Shapiro, Michael S. Seaman, John R. Mascola, Peter D. Kwong |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2023-12-01
|
| Series: | mAbs |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/19420862.2023.2165390 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
VERITAS: Harnessing the power of nomenclature in biologic discovery
by: Riti Biswas, et al.
Published: (2023-12-01) -
Improved pharmacokinetics of HIV-neutralizing VRC01-class antibodies achieved by reduction of net positive charge on variable domain
by: Young D. Kwon, et al.
Published: (2023-12-01) -
Tuning antibody stability and function by rational designs of framework mutations
by: Joseph C. F. Ng, et al.
Published: (2025-12-01) -
YAbS: The Antibody Society’s antibody therapeutics database
by: Puneet Rawat, et al.
Published: (2025-12-01) -
Improved antibody pharmacokinetics by disruption of contiguous positive surface potential and charge reduction using alternate human framework
by: Romain Ollier, et al.
Published: (2023-12-01)